TY - CHAP M1 - Book, Section TI - Fungal Infections in Patients with Cancer A1 - Granwehr, Bruno P. A1 - Kontoyiannis, Dimitrios P. A2 - Kantarjian, Hagop M. A2 - Wolff, Robert A. A2 - Rieber, Alyssa G. Y1 - 2022 N1 - T2 - The MD Anderson Manual of Medical Oncology, 4e AB - KEY CONCEPTSFungal infections are common in patients with cancer.Morbidity and mortality associated with fungal infection complicate cancer treatment outcomes.Invasive candidiasis is the most common fungal infection in patients with cancer, requiring careful assessment for dissemination, selection of appropriate antifungal agent, removal of infected devices, and duration of therapy.Invasive aspergillosis (IA) is the most common mold infection in patients with cancer, requiring vigilance to detect pulmonary or sinus infection, which may require resection or debridement in addition to aggressive antifungal therapy.Rare molds that infect patients with cancer include Fusarium and Mucorales spp., typically affecting patients with hematologic malignancy, with recovery of neutrophils the most important factor in improving mortality. SN - PB - McGraw Hill Education CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1190839554 ER -